HLB Life Science has ranked among the top searched stocks for 12 days in the past month.


As of 1:32 PM on the 5th, HLB Life Science is trading at 31,000 KRW, down 0.32% from the previous day. This marks a 42.2% increase compared to September 4. HLB Life Science is known as an engineering service company related to energy saving.

Today, foreigners have a net purchase of 38,000 shares of HLB Life Science, and institutions have a net purchase of 1,000 shares, according to provisional data. Over the past five days, individual investors have net purchased 53,423 shares, while foreigners and institutions have net sold 88,764 shares and net purchased 22,020 shares, respectively.


On September 29, HLB Life Science became a market issue with the news of an exclusive license agreement in Korea for 'Pyrotinib'.





[Table] Net Trading Volume of Foreigners and Institutions (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing